Navigation Links
NIRI San Diego May Meeting: Seasoned IROs Discuss "Tips & Tactics for Establishing and Maintaining A Successful Investor Relations Program"
Date:5/4/2012

SAN DIEGO, May 4, 2012 /PRNewswire/ -- The San Diego Chapter of the National Investor Relations Institute (NIRI) will host a panel discussion on "Tips & Tactics for Establishing & Maintaining a Successful Investor Relations Program" at the chapter's May 17, 2012 meeting.

The panel of seasoned IR professionals will discuss best practices developed during their careers, and share their unique perspectives on what makes an effective Investor Relations program.  Special emphasis will be placed on specific issues related to biotech and technology companies.

Whether you're new to Investor Relations or a long-term professional, this event will provide a thoughtful exchange and helpful advice for starting or enhancing an IR program.

Panelists:
Julie Cunningham - Vice President, Investor Relations and Corporate Communications, Mitek Systems. Julie brings 20 years of experience in corporate, financial and regulatory communications and extensive relationships with large, mid, and small-cap institutional investors and equity analysts, as well as national and financial media.

Nadine Padilla - Associate, Law Padilla. Nadine's expertise encompasses launching industry-leading products, countering attacks on public stocks, building the identities of innovative, growing companies.

Robert Uhl  - Managing Director, Westwicke Partners. Robert has 20 years of Wall Street experience on both the sell side and buy side, primarily as a financial analyst and as director of equity research. He also served as an investor relations officer at a biotechnology company.

Moderator:
Gwen Rosenberg - Vice President, Investor Relations & Corporate Communications, Senomyx, Inc. Gwen has 20 years of investor relations and corporate communications experience in the biotech and high tech sectors and has been recognized for her expertise with communications and crisis management.
'/>"/>

SOURCE NIRI San Diego
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. San Diegos Original Biotech Company Celebrates 30th Anniversary With Reunion
2. Amicus Therapeutics Opens Research Facility in San Diego
3. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
4. DermTech and Rady Childrens Hospital-San Diego, Initiate Study to Understand Effects of Vitamin D as a Treatment for Atopic Dermatitis in Children and Young Adults
5. Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs
6. Genetic clock makers at UC San Diego publish their timepiece in Nature
7. San Diego universities, government and industry rally around local Clean-Tech cluster
8. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
9. A Scientific Milestone: Sex of Dolphin at SeaWorld San Diego Determined Prior to Conception
10. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
11. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/26/2014)... (PRWEB) October 26, 2014 The ... Routers, ADC, Network Security Equipment, WAN Optimization Appliances]: ... and segments the data center networking market into ... of revenues. The report also identifies the factors ... opportunities impacting it along with the future roadmaps. ...
(Date:10/25/2014)... 25, 2014 The report “Adipic ... by Geography - Global Trends & Forecast to ... respect to market drivers, opportunities, and trends in ... and 27 figures spread through 217 slides and ... Trends & Forecast to 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , ...
(Date:10/25/2014)... BioProcess International (BPI), a business-to-business ... BioProcess International Awards. The awards celebrate the outstanding ... technology applications that will allow the industry to ... patient base. , Winners and finalists were honored ... entertaining and exciting awards dinner and ceremony yesterday ...
(Date:10/25/2014)... Iowa (PRWEB) October 24, 2014 ... Perdue plans to more than double the acreage ... in geographies supplying its soybean crush facility in ... from this program will target several markets including ... alternatives with good performance. , For the 2015 ...
Breaking Biology Technology:Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 2Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 3Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 4Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 2DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 3DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 4
... Regulus Therapeutics Inc ., a biopharmaceutical company leading the ... collaborators at NYU Langone Medical Center and Wake Forest ... pre-clinical research findings in the journal Nature ... 20, 2011). The new data show the first demonstration ...
... from the pivotal TEMSO Phase III study presented today at the joint ... Accepts New Drug Application for   Teriflunomide for relapsing forms ... SNY ) and its subsidiary Genzyme announced today new data ... O ral (TEMSO) Phase III trial showing that once-daily oral teriflunomide ...
... single-step process, engineers and scientists at the University ... to direct benign, filamentous viruses called M13 phages ... with a wide range of properties. By ... the viruses to self-assemble into hierarchically organized thin-film ...
Cached Biology Technology:Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 2Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 3Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 4Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 5Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 6Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 7Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 2Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 3Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 4Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 5Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 6Manufacturing goes viral 2Manufacturing goes viral 3Manufacturing goes viral 4
(Date:10/30/2014)... October 2014 Biological membranes are mainly composed of ... of solution ions onto lipid membranes helps clarify ... study provides a quantitative description of the equilibria ... Kotyńska and Zbigniew Figaszewski from the University of ... describing these findings, just published in EPJ ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
(Date:10/29/2014)... all the rage. Thousands of scientists worldwide are conducting ... titanium dioxide nanoparticles from sun creams can get through ... from electronic products are as hazardous for the lungs ... food can get into the blood via the intestinal ... are flowing – and the number of scientific projects ...
Breaking Biology News(10 mins):Ion adsorption matter in biology 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Nanosafety research: The quest for the gold standard 2Nanosafety research: The quest for the gold standard 3
... COLLEGE PARK, MARYLAND, April 29, 2009 -- In a ... , published by the American Institute of Physics (AIP), ... Berkeley and Los Alamos National Laboratory describe the first ... should help scientists design new experimental gene therapies and ...
... Cryoprotectants needed to preserve eggs for reproduction need to ... have developed a mathematical model that predicts optimal time for ... monkey eggs, which are very similar to human eggs, show ... the drugs needed to help protect eggs at subzero temperatures ...
... In the first neuroimaging study to examine motor ... Krieger Institute have uncovered important new insight into the ... the journal Brain ,s April 23 Brain Advanced ... functioning autism and their typically developing peers while performing ...
Cached Biology News:Simulated gene therapy 2Simulated gene therapy 3Drugs needed to preserve eggs for reproduction need to be given in stages 2Drugs needed to preserve eggs for reproduction need to be given in stages 3First neuroimaging study examining motor execution in children with autism reveals new insights 2First neuroimaging study examining motor execution in children with autism reveals new insights 3
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selecitivty and potential CNS-Side Effect liabilities of compo...
... Endogens Screening Sets contain the ... develop five colorimetric sandwich ELISA plates ... in 100 l/well of cell culture ... and Detection Antibodies, Recombinant Standard (5 ...
... The organic acid analysis standard ... six organic salts; molecular weights ... This standard is provided for ... column and the organic acid ...
Biology Products: